Pauline Michon

Pauline Michon

Auto-generated profile, based on publicly available information

Pauline Michon

Division of Molecular Metabolism, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CMChristina Martins
Christina Martins
LMLaure Migayron
Laure Migayron
CDClaire Drullion
Claire Drullion
CJClement Jacquemin
Clement Jacquemin
FLFabienne Lucchese
Fabienne Lucchese
KBKatia Boniface
Katia Boniface

1 November 2024 in Science Advances
Verified
Journal Article
Open access
MMMara Mennuni
Mara Mennuni
SWStephen E. Wilkie
Stephen E. Wilkie
PMPauline Michon
Pauline Michon
DADavid Alsina
David Alsina
RFRoberta Filograna
Roberta Filograna
NLNils-Göran Larsson
Nils-Göran Larsson
Lung adenocarcinoma is a common aggressive cancer and a leading cause of mortality worldwide. Here, we report an important in vivo role for mitochondrial DNA (mtDNA) copy number during lung adenocarcinoma progression in the mouse. We found that lung tumors induced by KRAS G12D expression have increased mtDNA levels and enhanced mitochondrial respiration. To experimentally assess a possible causative role in tumor progression, we induced lung cancer in transgenic mice with a general increase in mtDNA copy number and found that they developed a larger tumor burden, whereas mtDNA depletion in tumor cells reduced tumor growth. Immune cell populations in the lung and cytokine levels in plasma were not affected by increased mtDNA levels. Analyses of large cancer databases indicate that mtDNA copy number is also important in human lung cancer. Our study thus reports experimental evidence for a tumor-intrinsic causative role for mtDNA in lung cancer progression, which could be exploited for development of future cancer therapies.

23 September 2022
Verified
Conference Paper
Closed access
LDLea Dousset
Lea Dousset
PMPauline Michon
Pauline Michon
WMWalid Mahfouf
Walid Mahfouf
EMElodie Muzotte
Elodie Muzotte
GGGiulia Guzzo
Giulia Guzzo
HRHamid-Reza REZVANI
Hamid-Reza REZVANI
Dihydroorotate dehydrogenase (DHODH) is the rate-limiting enzyme in the uridine monophosphate (UMP) biosynthetic pathway and it is mostly located | POSTER

9 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
YPYann Le Pennec
Yann Le Pennec
NCNicolas Cluzel
Nicolas Cluzel
ITIssiaga Touré
Issiaga Touré
PMPauline Michon
Pauline Michon
JGJacques Geslin
Jacques Geslin
PRPierre ROQUES
Pierre ROQUES
Background: The recent resurgence of measles during the post-COVID-19 period represents a major public health concern worldwide, particularly for low- and middle-income countries (LMIC) like Guinea which has experienced recurrent measles epidemics, characterized by limited clinical surveillance. In this context, our study aimed to use environmental surveillance of wastewater to provide an effective and cost-efficient tool for monitoring measles virus circulation.Methods: In the absence of wastewater treatment plants in Guinea, our study was conducted in the semi-enclosed wastewater drainage networks, informal drainage networks and natural waterways. Measles virus detection in wastewater was performed using a simple, low-cost protocol adapted to LMIC. Measles quantification was normalized relative to the crAssphage signal, a quantitative indicator of the populations being monitored.Results: From August 2024 to October 2025, measles virus was detected in 32% of the wastewater samples analyzed (345/1072) with a clear peak during the early 2025 epidemic. This detection consistent with national clinical surveillance data demonstrates the value of wastewater monitoring as an early warning tool, helping to anticipate the resurgence of measles cases in the population.Interpretation: The modeling of our environmental surveillance adapted to a decentralized surveillance framework proposes an accurate characterization of the spatiotemporal dynamics of measles virus circulation in municipalities of Conakry and allows early alert about outbreaks before detection in health centers. This work demonstrates the feasibility of environmental surveillance in low-resource country settings and proves that it is a relevant tool during epidemic periods, helping to complement and strengthen the national surveillance system.

14 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JMJelena Misic
Jelena Misic
PRPablo Rivera-Mejías
Pablo Rivera-Mejías
CNClara Ursula Neumann
Clara Ursula Neumann
NHNico Hüttmann
Nico Hüttmann
PMPauline Michon
Pauline Michon
NLNils-Göran Larsson
Nils-Göran Larsson
Summary: Respirasomes have long been proposed to stabilize their constituent complexes. Yet the close relationship between individual complex biogenesis and respirasome formation has made it difficult to determine whether respirasomes are required for complex maintenance after assembly. Here, we uncoupled these processes using a genetic perturbation of the CI–CIII 2 contact site that severely depletes respirasomes while preserving individual complex assembly and function. Across orthogonal measures of protein stability, turnover and solubility, respiratory-chain maintenance remained largely preserved despite severe respirasome depletion in mouse embryonic fibroblasts, even under mitochondrial stress. We further tested whether a requirement for respirasomes emerges in vivo when OXPHOS biogenesis is progressively impaired through tissue- specific TFAM deletion. Respirasome depletion did not accelerate the loss of CI, CIII 2 or CIV during disease progression. Together, our findings show that respirasomes are not a major determinant of post-assembly respiratory-chain complex maintenance, even when mitochondrial homeostasis and OXPHOS biogenesis are challenged.

7 April 2026
Verified
Thesis
Closed access
PMPauline Michon
Pauline Michon
Le carcinome épidermoïde (CEC) est le cancer cutané le plus agressif après le mélanome. Il est en constante augmentation du faitdu vieillissement de la population et de l’exposition trop excessive aux UVB. Ce cancer évolue en différents stades allant de la lésionprécancéreuse, à la tumeur primaire jusqu’à atteindre le stade métastatique. Ces différents stades sont bien établis cliniquementmais aucun outil n’est à ce jour disponible afin de nous permettre de prédire les risques qu’à la lésion précancéreuse d’évoluer etses risques de métastaser. L’identification des signatures génétiques étant difficile à obtenir du fait du grand nombre de mutationscausées par les UV, nous avons décidé de nous intéresser aux signatures métaboliques et immunitaires du CEC.Dans une première partie, nous nous sommes intéressés à l’impact des dimères cyclobutyliques de pyrimidine (CPD) nucléaireset/ou mitochondriales sur la reprogrammation métabolique après une exposition aux UV. Pour cette étude, des kératinocytesexprimant des photolyases nucléaires et mitochondriales ont été utilisés. Une étude protéomique et métabolomique a ainsi mis enévidence une modification biphasique des acteurs du métabolisme dépendante des CPD génomique. Nous avons aussi montré uneaugmentation de la consommation d’oxygène 24h après irradiation et une modification de la dynamique mitochondriale dépendantesdes CPD nucléaires et mitochondriales.Dans une seconde partie nous avons étudié le profil métabolique de différentes lignées de CEC et de différentes tumeurs de patientsà différents stades de la carcinogénèse. Des analyses protéomiques et biochimiques ont mis en évidence trois profils métaboliques.La croissance tumorale s’est avérée différente en fonction des profils. L’administration du Leflunomide, inhibiteur de l’enzymeDHODH impliquée à la fois dans la voie de synthèse des pyrimidines et le métabolisme mitochondrial, s’est révélé efficace pourcertaines lignées et plus particulièrement celles exprimant de façon plus importante l’enzyme. Ainsi, DHODH pourrait être un potentielmarqueur prédictif de l’efficacité du leflunomide.Le microenvironnement a un rôle central dans la progression tumorale et l’identification de nouvelles signatures immunitaires. Danscette dernière partie, nous avons analyser l’expression des cytokines par transcriptomique et nous avons mis en évidence différentessignatures immunitaires.Nos résultats ont ainsi pu révéler de nouveaux biomarqueurs métaboliques et immunitaires à différents stades de la carcinogénèsecutanée.